Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126169151 | 12616915 | 1 | I | 20160229 | 20160802 | 20160802 | PER | ES-LUPIN PHARMACEUTICALS INC.-2016-00994 | LUPIN | IZQUIERDO N, CONDE A, FERNANDEZ L, PEREZ N, SOLER P, ASENJO J. HERPES SIMPLEX VIRUS ENCEPHALITIS IN PREGNANCY. J-PERINAT-MED. 2015;43:. | 33.00 | YR | F | Y | 0.00000 | 20160801 | COUNTRY NOT SPECIFIED | ES |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126169151 | 12616915 | 1 | PS | LEVETIRACETAM. | LEVETIRACETAM | 1 | Unknown | UNKNOWN | 78154 | ||||||||||
| 126169151 | 12616915 | 2 | C | ACYCLOVIR. | ACYCLOVIR | 1 | Intravenous (not otherwise specified) | 750 MG | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126169151 | 12616915 | 1 | Generalised tonic-clonic seizure |
| 126169151 | 12616915 | 2 | Herpes simplex encephalitis |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126169151 | 12616915 | Exposure during pregnancy | |
| 126169151 | 12616915 | Skin discolouration | |
| 126169151 | 12616915 | Tooth discolouration |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |